Secondary Analysis of PTSD Genome Wide Association Study Data Published in Cell Reports

PTSD & TBI Research
Cohen Veterans Bioscience is proud to co-fund this study which is a secondary analysis of the data from our 2019 Post-Traumatic Stress Disorder (PTSD) Genome Wide Association Study to better understand how the expression of certain genes may affect vulnerability to PTSD and may provide insights for prevention and treatment.

In the face of repeated, prolonged, or severe trauma, some individuals seem to be more susceptible to PTSD while others are resilient. Identifying which individuals may be susceptible to PTSD‚ and why, can help researchers develop effective interventions.

Read the study in Cell Reports and learn more here.

Share this article:

More from CVB

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

New meta-analysis builds upon PTSD genetics research, providing a foundation for the development of precision therapies

Driving Progress: TBI Action Alliance Launches Multi-Pronged Initiative to Speed Development of Diagnostic and Therapeutic Solutions for Traumatic Brain Injury

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.